Michael Gibertini, President Clinical Development at INC Research Holdings, Inc. (INCR), sold 211,989 shares at $43.84 ($9.1M) on 2016-06-06, disclosed to the SEC on 2016-06-07.
Open-market sale of $9.1M INCR by President Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.05 | 16,652 | $717K | 7.8% |
| 2 | $43.05 | 26,394 | $1.1M | 12.4% |
| 3 | $43.05 | 144,682 | $6.2M | 68.2% |
| 4 | $43.19 | 13,751 | $594K | 6.5% |
| 5 | $43.83 | 9,034 | $396K | 4.3% |
| 6 | $43.84 | 1,476 |
| $65K |
| 0.7% |
| Total | $43.10 avg | 211,989 | $9.1M | 100% |
| Filing → |
| INCR | SELL | 2016-04-04 | $367K | — | Filing → |
| INCR | SELL | 2016-03-02 | $359K | — | Filing → |
| INCR | SELL | 2016-02-02 | $365K | — | Filing → |